MEDI-528, now recognized as enokizumab , represents a groundbreaking therapeutic targeting the IGF-1R , a vital protein linked in various dermatological diseases . Early clinical results suggest https://arungtsa615774.wikimidpoint.com/7186793/enokizumab_a_deep_dive_into_medi_528_and_its_potential